IRIS - Res&Arch Institutional Research Information System - Research & Archive

AVERSA, Franco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.806
EU - Europa 1.413
AS - Asia 467
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 3.688
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.801
IE - Irlanda 347
UA - Ucraina 304
SE - Svezia 242
IT - Italia 181
HK - Hong Kong 138
SG - Singapore 110
CN - Cina 97
FI - Finlandia 88
VN - Vietnam 77
DE - Germania 62
RU - Federazione Russa 60
GB - Regno Unito 47
KR - Corea 22
FR - Francia 15
TR - Turchia 15
BE - Belgio 13
CZ - Repubblica Ceca 12
AT - Austria 10
CH - Svizzera 9
NL - Olanda 7
GR - Grecia 6
PL - Polonia 5
CA - Canada 4
LB - Libano 3
RO - Romania 2
UZ - Uzbekistan 2
BG - Bulgaria 1
BR - Brasile 1
EE - Estonia 1
EU - Europa 1
IN - India 1
JP - Giappone 1
MX - Messico 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 3.688
Salva come PNG Salva come JPEG
Città #
Chandler 393
Dublin 345
San Mateo 200
Jacksonville 169
Hong Kong 138
Boardman 136
Dong Ket 77
Singapore 77
Medford 69
Princeton 68
Ann Arbor 58
Andover 55
Perugia 53
Altamura 50
Wilmington 43
Lawrence 42
Beijing 40
Helsinki 30
Des Moines 21
Saint Petersburg 21
Ashburn 19
Houston 19
New York 17
Woodbridge 17
Norwalk 16
Seoul 16
Shanghai 14
Izmir 13
Los Angeles 13
Santa Clara 13
Auburn Hills 11
Brussels 11
San Paolo di Civitate 11
Brno 9
Dallas 7
Dearborn 7
Moscow 7
Vienna 7
Falls Church 6
Renton 6
Bologna 4
Hanover 4
Redmond 4
Redwood City 4
Rome 4
Salerno 4
Aurora 3
Den Haag 3
Foligno 3
Munich 3
Olomouc 3
Ottawa 3
San Diego 3
Seattle 3
Amsterdam 2
Bupyeong-gu 2
Edinburgh 2
Eunpyeong-gu 2
Groningen 2
Kocaeli 2
Kunming 2
Naples 2
Oklahoma City 2
San Daniele del Friuli 2
Santarcangelo di Romagna 2
Shenzhen 2
West Jordan 2
Zaventem 2
Ancona 1
Athens 1
Atlanta 1
Boydton 1
Bratislava 1
Bucharest 1
Castelnuovo Berardenga 1
Chicago 1
Como 1
Dong-gu 1
Florence 1
Fort Worth 1
Garson 1
Guangzhou 1
Hefei 1
Hyderabad 1
Lappeenranta 1
Las Vegas 1
London 1
Ludwigshafen 1
Manchester 1
Marsala 1
Milan 1
Mirano 1
Phoenix 1
Piediluco 1
Port Saint Lucie 1
Reggio Emilia 1
Riyadh 1
San Benedetto Del Tronto 1
San Giustino 1
Secaucus 1
Totale 2.432
Salva come PNG Salva come JPEG
Nome #
Advances in full-haplotype mismatched transplants in acute leukemia 125
Alloreactive natural killer cells in mismatched hematopoietic stem cell transplantation 86
Graft engineering for allogeneic haploidentical stem cell transplantation 86
Comparison of immunosuppressive effects of single-dose and hyperfractionated total body irradiation 80
Acute lymphoblastic leukaemia in Noonan syndrome 80
Fourth international workshop on haploidentical transplants, Naples, Italy 79
A survey of fully haploidentical hematopoietic stem cell transplantation in adults with high-risk acute leukemia: a risk factor analysis of outcomes for patients in remission at transplantation. 77
Natural killer cell recognition of missing self and haploidentical hematopoietic transplantation. 74
Haploidentical stem cell transplantation for acute leukemia 71
Hematopoietic stem cell transplantation from alternative sources in adults with high-risk acute leukemia. 71
Addition of PBPCs to the marrow inoculum allows engraftment of mismatched T cell-depleted transplants for acute leukemia 70
Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation. 69
Haploidentical transplantation and natural killer cell recognition of missing self. 66
A multidrug-resistant Pseudomonas aeruginosa isolate from a lethal case of sepsis induces necrosis of human neutrophils 65
null 63
Full-haplotype mismatched HSCT for high risk acute myeloid leukemia (AML). 63
PML is required for telomere stability in non-neoplastic human cells 62
Stem cell mobilization in normal donors. 60
Immunotherapy with alloreactive natural killer cells in haploidentical haematopoietic transplantation. 60
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants 60
Hematopoietic stem cell transplantation (HSCT) from alternative donors for acute leukemia at high-risk of relapse. the haploidentical option. 59
Toxoplasma gondii infection in bone marrow transplant recipients: the polymerase chain reaction-blood sample combination in diagnosis and early detection. 58
Natural killer cell alloreactivity and haplo-identical hematopoietic transplantation. 57
Full haplotype-mismatched hematopoietic stem-cell transplantation: A phase II study in patients with acute leukemia at high risk of relapse 57
Clinical impact of natural killer cell reconstitution after allogenic hematopoitic transplantation.Immunobiology working Party of the European Group for Blood and Marrow Transplantation 57
Totipotent stem cells bearing del(20q) maintain multipotential differentiation in Shwachman Diamond syndrome 56
"Designed" grafts for HLA-haploidentical stem cell transplantation. 55
Donor activating KIR genes and control of infections after haploidentical haematopoietic transplantation 55
Mismatched hematopoietic stem cell transplantation in secondary leukemia 54
HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse 54
HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse 54
Genetic polymorphisms affecting IDO1 or IDO2 activity differently associate with aspergillosis in humans 54
Polymorphisms in Toll-like receptor genes and susceptibility to infections in allogeneic stem cell transplantation. 52
Competing risks analysis using R: an easy guide for clinicians 52
Stem cell transplantation from full-haplotype mismatched donors in leukemia . 50
Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value. 49
New mechanism of lymphoma-induced bone marrow aplasia 49
Outcomes of unrelated cord blood and haploidentical stem cell transplantation in adults with acute leukaemia. 48
Improved Outcome With T-Cell–Depleted Bone Marrow Transplantation for Acute Leukemia 47
Survival after T cell-depleted haploidentical stem cell transplantation is improved using the mother as donor. 46
null 46
Deploying natural killer cell allotherapy in the setting of HLA-haplotype-mismatched hematopoietic stem cell transplantation 46
Cataracts in patients receiving stem cell transplantation after conditioning with total body irradiation 45
Natural killer cell allorecognition of missing self in allogenic hematopoietic transplantation :a tool for immunotherapy of leukemia. 45
Hematopoietic stem cell transplantation from alternative donors for high-risk acute leukemia: the haploidentical option. 44
Full-haplotype mismatched HSCT is a valid option for high-risk acute myeloid leukemia (AML) patients. 43
Prognostic significance of genetic variants in the IL-23/Th17 pathway for the outcome of T cell-depleted allogeneic stem cell transplantation. 42
Outcomes after CD34+ positive immunoselection for haploidentical transplants in high-risk acute leukemia. 41
A High-Risk Profile for Invasive Fungal Infections Is Associated with Altered Nasal Microbiota and Niche Determinants 41
Infezioni da Cytomegalovirus nel paziente immunodepresso. 40
Transplantation of haploidentically mismatched stem cells for the treatment of malignant diseases 39
Prospects for dendritic cell vaccination against fungal infections in hematopoietic transplantation 39
The Evolution of T Cell Depleted Haploidentical Transplantation 39
Optimizing therapeutic outcomes of immune checkpoint blockade by a microbial tryptophan metabolite 39
Linking genomic lesions with minimal residual disease improves prognostic stratification in children with T-cell acute lymphoblastic leukaemia. 38
Thymosin Alfa 1 Administration Improves Immune Reconstitution and Decreases Infection-Related Mortality After HLA-Matched Sibling T Cell-Depleted Stem Cell Transplantation. 38
Regression Modeling of Competing Risk Using R: An In Depth Guide for Clinicians 37
null 36
The role of bronchoalveolar lavage (BAL) in immunocompromised haematological patients. 36
Pharyngeal microbial signatures are predictive of the risk of fungal pneumonia in hematologic patients 36
Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study--Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne. 34
Thymosin Alfa 1 Administration Improves Immune Reconstitution and Decreases Infection-Related Mortality After HLA-Matched Sibling T Cell-Depleted Stem Cell Transplantation. 34
Liposomal amphotericin B (AmBisome®) at beginning of its third decade of clinical use 34
The haploidentical option for high-risk haematological malignancies. 33
Haploidentical stem cell transplantation in leukemia 33
Hairy cell leukaemia mimicking multiple myeloma 31
Febrile events in acute lymphoblastic leukemia: a prospective observational multicentric SEIFEM study (SEIFEM-2012/B ALL) 27
Systemic antifungal treatment after posaconazole prophylaxis: results from the SEIFEM 2010-C survey 26
Haploidentical hematopoietic transplantation from KIR ligand-mismatched donors with activating KIRs reduces non-relapse mortality 25
Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey 24
Haploidentical hematopoietic stem cell transplantation with a megadose T-cell-depleted graft: harnessing natural and adaptive immunity. 24
Natural killer cells as a therapeutic tool in mismatched transplantation 24
Identification of an Epi-metabolic dependency on EHMT2/G9a in T-cell acute lymphoblastic leukemia 23
T-cell–depleted haploidentical stem cell transplantation results improve with time in adults with acute leukemia: A study from the Acute Leukemia Working Party of the European Society of Blood and Marrow Transplantation (EBMT) 23
Hematopoietic Cell Transplantation from Human Leukocyte Antigen Partially Matched Related Donors 22
Provision of antifungal immunity and concomitant alloantigen tolerization by conditioned dendritic cells in experimental hematopoietic transplantation. 19
Risk of invasive fungal infection in patients affected by acute promyelocytic leukaemia. A report by the SEIFEM-D registry 18
Pre-chemotherapy risk factors for invasive fungal diseases: prospective analysis of 1,192 patients with newly diagnosed acute myeloid leukemia (SEIFEM 2010-a multicenter study) 18
Orthogonal proteogenomic analysis identifies the druggable PA2G4-MYC axis in 3q26 AML 14
null 11
Totale 3.837
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.409
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.409
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020305 0 0 50 4 45 7 53 5 51 34 11 45
2020/2021640 5 41 29 42 170 44 50 5 75 31 58 90
2021/2022650 13 165 25 47 19 4 9 190 6 13 73 86
2022/20231.202 81 197 9 102 129 118 2 66 443 11 34 10
2023/2024491 26 60 25 8 8 6 108 12 61 18 73 86
2024/2025208 26 119 63 0 0 0 0 0 0 0 0 0
Totale 3.837